{
    "nctId": "NCT05846997",
    "briefTitle": "Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy",
    "officialTitle": "Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Identification of novel micro-invasive predictors of pathological complete response (pCR) during neo-adjuvant therapy.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u2265 18 years\n2. Histological Diagnosis of Infiltrating Breast Cancer.\n3. The presence of measurable mammary lesions;\n4. The presence of metabolically active mammary lesions;\n5. Performance Status (Eastern Cooperative Oncology Group scale, ECOG) \u2264 1;\n6. Compliance with periodic blood withdrawal;\n7. Compliance with periodic PET/CT and RMN imaging;\n8. Adequate clinical and laboratory test results for undertaking neoadjuvant chemotherapy and surgery;\n9. Written informed consent.\n\nExclusion Criteria:\n\n1. The presence of contraindications for the execution of RMN and PET-TC;\n2. Presence of metastatic disease;\n3. Pre-existing or concurrent tumors, except in situ carcinoma or basophilic carcinoma of the skin;\n4. Uncontrolled active infections;\n5. Insufficient patient compliance;\n6. Absence of signed informed consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}